Search Results 341-350 of 17626 for Glucocorticoids

1. The Impact of Training with Whole Body EMS - Mayo Clinic

   Subjects under the age of 18. · Pregnant women. · Subjects with a history of liver or kidney disease, acute illness, taking medications (such as glucocorticoids).

2. Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev® Insulin Lispro-aabc - Mayo Clinic

   ... glucocorticoids within 8 weeks; from time of screening visit, or plans to take any oral, injectable, or IV glucocorticoid during the course of the study. Is ...

3. A Study of Donor-Alloantigen-Reactive Regulatory T Cell Therapy with an Immunosuppression Regimen in Adult Liver Transplantation - Mayo Clinic

   Chronic use of systemic glucocorticoids or other Immunosuppression (IS), or biologic immunomodulators. Chronic condition requiring anti-coagulation after ...

4. IL-4 and Insulin Resistance for Treatment of Patients with Atopic Dermatitis - Mayo Clinic

   - Diagnosis of Atopic Dermatitis treated with topical steroids or phototherapy. Exclusion Criteria: - Any prescription for systemic glucocorticoid, ...

5. Publications - Jessica R. Wilson, M.D. - Mayo Clinic

   Individual-specific functional epigenomics reveals genetic determinants of adverse metabolic effects of glucocorticoids. Cell Metab. 2021 Aug 3; 33 (8):1592 ...

6. Macimorelin (oral route) - Mayo Clinic

   Glucocorticoid (steroid) deficiency or; Sex hormone deficiency or; Thyroid deficiency—Your doctor may tell you to replace these missing hormones before ...

7. Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes - Mayo Clinic

   Use of systemic glucocorticoids (excluding topical or ophthalmic application or inhaled forms) for more than 10 consecutive days within 12 weeks prior to the ...

8. Study Evaluating ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... glucocorticoids. For United States (US) Subjects: Daratumumab combination regimen must be one of the prior lines of therapy (for this study, daratumumab ...

9. Neoadjuvant dual checkpoint blockade with PD1 and LAG-3 inhibition in resectable Non-small cell lung Cancer - Mayo Clinic

   ... glucocorticoids to assist with management, or pneumonitis within the last 5 years. Autoimmune disease (including any history of inflammatory bowel disease).

10. DN24-02 as Adjuvant Therapy in Subjects with High Risk HER2+ Urothelial Carcinoma - Mayo Clinic

    Systemic glucocorticoid or immunosuppressive therapy use ≤ 28 days prior to registration. Any infection requiring parenteral antibiotic therapy or causing ...